Natural Alternatives International (Natural Alternatives International) Risk Assessment

View and export this data going back to 1993. Start your Free Trial

What is Natural Alternatives International Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Natural Alternatives International is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Natural Alternatives International's Risk Assessment

For the Packaged Foods subindustry, Natural Alternatives International's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natural Alternatives International's Risk Assessment Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Natural Alternatives International's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Natural Alternatives International's Risk Assessment falls into.

Natural Alternatives International (NAS:NAII) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Natural Alternatives International Risk Assessment Related Terms

Thank you for viewing the detailed overview of Natural Alternatives International's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Natural Alternatives International (Natural Alternatives International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Natural Alternatives International Inc (NAS:NAII) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

NA2:Germany

Address

1535 Faraday Avenue, Carlsbad, CA, USA, 92008

Website

https://www.nai-online.com

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Executives

Mark A Ledoux	director, 10 percent owner, officer: CEO/Chairman	1185 LINDA VISTA DR, SAN MARCOS CA 92069
Joe E Davis	director	3436 CARIBETH DR, ENCINO CA 91436
Lee G Weldon	director	1185 LINDA VISTA DRIVE, SAN MARCAS CA 92069
Alan G Dunn	director	1185 LINDA VISTA DR., SUITE A, SAN MARCOS X1 92078
Michael E Fortin	officer: Chief Financial Officer	1185 LINDA VISTA DRIVE, SAN MARCOS CA 92078
Kenneth Wolf	officer: Chief Financial Officer	12626 HIGH BLUFF DRIVE, SUITE 440, SAN DIEGO CA 92130
Alan J Lane	director	41090 AVENIDA VERDE, TEMECULA CA 92591
Guru Ramanathan	director	C/O GNC HOLDINGS, INC., 300 SIXTH AVENUE, PITTSBURGH PA 15222
Laura Kay Matherly	director	1535 FARADAY AVENUE, CARLSBAD CA 92008
Edward Borg	10 percent owner	600 SOUTH US HIGHWAY 1, APT. 609, JUPITER FL 33477
Alvin Mccurdy	officer: V.P. of Operations	1185 LINDA VISTA DR., SUITE A, SAN MARCOS CA 92078
Carl J Terranova	other: Member of 13(d) 10% group	159 CHRYSTIE ST, NEW YORK NY 10002
Thomas H Hansen	10 percent owner
John Dullea	officer: President, RHL (Subsidiary)	12189 CAMINITO CORRIENTE, SAN DIEGO CA 92128
Randell Weaver	officer: President